Most Recent Notable Mergers

 

By Nancy Zambell
Editor of Investment Digest and Dividend Digest

---

Merger and Acquisition is on Track for a Banner Year

Most Recent Notable Mergers

Signals of M&A Catalysts

---

In January of this year, KPMG estimated that 2015’s merger and acquisition activity would top the $1.62 trillion in marriages created in 2014. So far this year, Dealogic says global M&A is $593 billion YTD, up from $536 billion in 2014 YTD, and the highest since the $677 billion booked in 2007.

The industries expected to be very active are healthcare, pharmaceuticals, life sciences, followed by technology, media, telecom—and bringing up the rear—energy, oil and gas. And so far—at least as far as healthcare and media are concerned—that forecast is proving true.

Healthcare M&A stands at 464 deals, for $92.0 billion—up 63%; Technology M&A is down 5%, to $72.7 billion, but the number of deals—1,797—is 24% higher. Telecom M&A volume has dropped 59%, to $59.9 billion, but deals are up from 147 last year to 189 in 2015. Media combinations have risen 43%, to $3.8 billion, on 136 deals.

Just this month, we’ve seen several notable merger announcements on stocks that we have covered in our Investment Digest or Dividend Digest, including:

AbbVie (ABBV) March 4 announcement that it would acquire Pharmacyclics (PCYC) for $21.0 billion. John McCamant and Jay Silverman of the Medical Technology Stock Letter recommended PCYC in Investment Digest 759, July 23, 2014 Mid-Year Top Picks issue.

Hewlett-Packard (HPQ) announced plans to buy wi-fi network gear maker Aruba Networks (ARUN) for about $2.7 billion, also on March 4. Aruba was recommended in Investment Digest 749, September 18, 2013, by David C. Jennett in his Investment Letter.

• Warren Buffett’s Heinz announced $50 billion takeover of Kraft Foods (KRFT) on March 25. John Stephenson of the MoneyLetter recommended Kraft in our Dividend Digest 245, February 13, 2013.

Since the merger announcements, Pharmacyclics’ shares have risen 18.4%; Kraft’s are up 45.3%; and Aruba’s shares haven’t done much since the announcement, but have increased 34.7% in 2015 (perhaps the word got out early?)

With numbers like these, it’s no surprise that investors are always searching for companies that might be taken over at a premium. And in my years of investing, I’ve seen that happen a lot. In fact, several companies that I had recommended (including Justin Industries and Clayton Homes) became targets of Buffett’s Berkshire Hathaway, giving subscribers very nice double-digit returns.

--- Advertisement ---

Steal the Money-Doubling Stock Picks of Wall Street's Top Guns

But Hurry: Only a Few Spots Remain

Joining will let you profit from Wall Street's leading analysts' top recommendations, like these, sent to you daily:

• 1,683% in Questcor from Richard Schmidt of Stellar Stocks Alert
• 1,111% in Netflix from Ron Rowland of All-Star Investor
• 857% in Baidu from Charles B. Carlson CFA of Drip Investor
• 778% in Apple from Alan B. Lancz of The Lancz Letter
• 728% in Valeant Pharmaceuticals from Ronald Sadoff of Major Trends
• 545% in SanDisk from George Putnam III of The Turnaround Letter
• 520% in Chipotle from Patrick McKeough of Stock Pickers Digest
• 454% in Priceline from Louis Navellier of Blue Chip Growth
• 389% in Headwaters from Nick Hodge of Alternative Energy Speculator

But you’ll have to hurry.

This offer is limited to 14 Cabot readers who RSVP!

So what are you waiting for?

You're guaranteed 30 money doubling picks each month plus Daily Alerts sent directly to your inbox—all without you risking a dime.

Click here now to steal the top picks of Wall Street’s Top Guns today.

---

Of course, M&A is just one example of what I call “Special Situations” that can create immediate gains for shareholders. Others include spin-offs, special dividends, stock buybacks and private equity buyouts.

And if you are lucky enough to be an investor in one of these companies, you may see some hefty benefits in rising stock prices when such a catalyst occurs.

But astute investors don’t want to rely simply on luck for a successful investment strategy. Instead, they want to buy companies with all the right characteristics to benefit from one of these catalysts before the event happens. And while nothing is foolproof, there are a few indicators that might help you identify companies with the “right stuff” early, so you can get in before the big announcement that sends prices soaring.

I call these characteristics “Signals of Catalysts,” and they include:

• Rise in Institutional Interest
• Increase in Volume
• Sector/Industry Growth
• Market Share Leadership
• Large Cash Positions
• Change in Company Focus
• Need for Cash Influx
• New Management

There are many stock screeners (my favorite is finviz.com) that can help you filter several of these parameters, such as change in institutional interest, volume increases, and cash positions. For the others, you’ll have to rely on perusing 10-Ks and news stories, to find potential opportunities.

But before you invest in any stock, please recognize that even if a company meets all the above qualifications, there’s no guarantee that it will be bought, spun-off, issue a special dividend, etc.

Consequently, you want to first make sure that the company meets your essential requirements to fit into your portfolio for the long term—because it may be there for the long term.

So, run every stock through your investing qualifications first. And if it passes those tests, then use the above criteria to determine if the stock may fall into the “possible special event” category that could propel its shares to a new level—sooner rather than later.

Sincerely,

Nancy Zambell
Editor, Investment Digest and Dividend Digest

P.S. Don’t miss out on the opportunities to profit from the future mergers and acquisitions.

Investment Digest covers investment recommendations from the top gurus on Wall Street allowing you to get in on the ground floor of the best investment opportunities in the market. With 30 top recommendations, follow-ups and daily alerts, you’ll receive the best picks across the spectrum of investing.

Click here for more details. 


Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >